Tele: 561.316.3330
Breaking Medical Device News

Tuesday, October 19, 2021

HomeBIOTECHNOLOGYCorrelation of Campbell Score with Suicidal Ideation Clinical Trial Shows Positive Preliminary...

Correlation of Campbell Score with Suicidal Ideation Clinical Trial Shows Positive Preliminary Data Advises Therapeutic Solutions International

January 13, 2021

Correlation of Campbell Score with Suicidal Ideation federally listed clinical study show positive preliminary data. From a group of four healthy controls and four patients with suicidal ideations, the patients with suicidal ideations possessed approximately 3-fold higher levels of the inflammatory cytokine as compared to controls (24.2 ± 7.7 pg/ml vs 8.4 ±2.9 pg/ml).

The clinical trial is planned to recruit an additional 22 patients and aims to establish the validity of the Campbell Score™ as an objective marker to quantify risk of suicide.

“Currently there are no objective means of knowing the true risk factor for a patient to kill themselves,” said Dr. James Veltmeyer, Chief Medical Officer of Therapeutic Solutions International and Campbell Neurosciences. “We believe the Campbell Score™ is a first in class diagnostic tool which will not only prevent suicides but will be utilized as a tool for personalizing dosages of various psychiatric medicines and interventions.”

The Campbell Score™ is currently being developed by Campbell Neurosciences, a partially-owned spinoff of Therapeutic Solutions International.

“More people die of suicide than in all the wars and natural disasters combined,” said Kalina O’Connor, President and Chief Executive Officer of Campbell Neurosciences. “By bringing advanced immunological sciences to the area of psychiatry, we believe we can positively impact the only field of medicine that does not routinely interrogate the organ it is treating.”

“Quite exciting to us as a Company is the fact that our nutraceutical product QuadraMune™, which is currently in clinical trials for prevention of COVID-19,2 has been demonstrated to reduce concentrations of the same inflammatory markers assessed in the Campbell Score™,” said Famela Ramos, Vice President of Business Development for Therapeutic Solutions International. “We are eager to initiate clinical trials utilizing science-based nutraceutical approaches as mono-therapies or adjuvants to existing therapies in order to effectively reduce brain inflammation and inhibit suicidal thoughts.”

“The expedience of the Campbell Team in conducting the ongoing trial is unparalleled,” said Timothy Dixon, President and CEO of Therapeutic Solutions International. “It is an honor to synergize with the work of Miss O’Connor and her team, who are dedicated to finding a cure to suicide using a regenerative psychiatry approach.  Therapeutic Solutions International is an “Innovation Factory” with programs in cell therapy, immunology, and nutraceuticals.  Through working with Campbell Neurosciences, we provide broad and deep intellectual property while allowing Campbell Neurosciences to remain laser-focused on their mission of “curing suicide.”

Medical Device News Magazine
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected


Don't Miss

Adam S. Epstein New CEO of AliMed, Inc.

In his prior role as Chief Commercial Officer, Epstein directed all customer-facing, demand generation and product development activities. Under his new leadership, AliMed will continue to build a robust portfolio of contracted positions with major, national GPO’s, IDN’s, and Distribution partners to drive sales growth.

Tony Collins Appointed CFO of Xenter

“Xenter is building a platform for medical innovations that is transformational. The only way we can achieve our objectives is if we have great leaders like Tony Collins leading our company,” stated Richard J. Linder, Founder, Chairman & CEO of Xenter, Inc. “Tony brings incredible depth and experience to his new role as Chief Financial Officer.

Scott Sexton Appointed President at FIGUR8

"Scott brings to FIGUR8 30 years of workers' compensation, casualty, disability, and commercial health experience, most recently serving as a market leader for CorVel's national carrier practice sales team," said Nan-Wei Gong, CEO, and co-founder of FIGUR8.

Insulet Announces Board of Director Changes with Appointment of Luciana Borio, M.D. and Retirement of Sally W. Crawford

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced...

Ganymed Robotics Awarded a €2.5M Grant from the EC through the EIC Accelerator Program

Ganymed Robotics is developing a radically new approach to surgical robotics by combining computer vision, a branch of artificial intelligence, and mechatronics.

Global Healthcare Exchange Announces Acquisition of Explorer Surgical

Explorer Surgical will operate as a wholly-owned subsidiary of GHX.

By using this website you agree to accept Medical Device News Magazine Privacy Policy